Cite
Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
MLA
Swamy, N., et al. “Molecular Modeling, Affinity Labeling, and Site-Directed Mutagenesis Define the Key Points of Interaction between the Ligand-Binding Domain of the Vitamin D Nuclear Receptor and 1 Alpha,25-Dihydroxyvitamin D3.” Biochemistry, vol. 39, no. 40, Oct. 2000, pp. 12162–71. EBSCOhost, https://doi.org/10.1021/bi0002131.
APA
Swamy, N., Xu, W., Paz, N., Hsieh, J. C., Haussler, M. R., Maalouf, G. J., Mohr, S. C., & Ray, R. (2000). Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3. Biochemistry, 39(40), 12162–12171. https://doi.org/10.1021/bi0002131
Chicago
Swamy, N, W Xu, N Paz, J C Hsieh, M R Haussler, G J Maalouf, S C Mohr, and R Ray. 2000. “Molecular Modeling, Affinity Labeling, and Site-Directed Mutagenesis Define the Key Points of Interaction between the Ligand-Binding Domain of the Vitamin D Nuclear Receptor and 1 Alpha,25-Dihydroxyvitamin D3.” Biochemistry 39 (40): 12162–71. doi:10.1021/bi0002131.